Amferia AB
Share:
Subscribe:
news.cision.com
/
Amferia AB
/
Following the U.S. FDA De Novo Classification, Amferia Seeks Potential Partners to Market the World’s First Antibacterial Peptide-Based Wound Dressing
/
Anand Linkedin ad
Anand Linkedin ad
Wed, Apr 29, 2026 12:04 CET
Low resolution
Medium resolution
Original resolution
Subscribe
